Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci

被引:18
|
作者
Davis, John W. [1 ]
Kim, Jeri [4 ]
Ward, John F.
Wang, Xuemai [3 ]
Nakanishi, Hiro
Babaian, R. Joseph
Troncoso, Patricia [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Unit 1373, Dept Urol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
关键词
prostate cancer; active surveillance; radical prostatectomy; ACTIVE SURVEILLANCE; SELECTING PATIENTS; MEN; FEATURES; ADENOCARCINOMA; VALIDATION; CANDIDATES; MANAGEMENT; NOMOGRAM; UPDATE;
D O I
10.1111/j.1464-410X.2009.08964.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To measure total tumour volume (TTV) and dominant TV (DTV) in radical prostatectomy (RP) specimens from patients predicted to have low-volume, low-grade (LV/LG) prostate cancer, as this entity can be predicted from biopsy findings and prostate-specific antigen (PSA) level, but tumour under-sampling remains a challenge in active surveillance programmes. PATIENTS AND METHODS This was a retrospective study from an academic centre, of men with prostate cancer treated from 2000 to 2007, with a PSA level of < 10 ng/mL and one core of cancer from an extended scheme showing either Gleason score (GS) 3 + 3 of < 3.0 mm or 3 + 4 of < 2.0 mm. All men had RP, and the TTV, DTV, tumour location, pathological GS and stage were measured. RESULTS Of 3055 RPs, 66 (2.1%) met the inclusion criteria. The core with cancer was from a sextant and alternative site in 26 (39%) and 40 (61%) patients, respectively. A pathological GS 3 + 3 or 3 + 4 was assigned to 94%, while 6% were GS >= 4 + 3; all 66 tumours were organ-confined. The median (range) TTV and DTV were 0.15 (0.0008-5.06) and 0.14 (0.0008-5.04) mL, respectively. The median number of tumour foci was 3 (1-7), being unifocal in 17/66 (26%) and multifocal in 49/66 (74%). The transition zone was involved in 29% of unifocal and 71% of multifocal tumours. Of all 66 patients, the TTV was < 0.5 mL in 47 (71%), and of 59 patients with biopsy GS 3 + 3, 33 (56%) had a TTV of < 0.5 mL and pathological GS 3 + 3. Of 19 patients with a TTV of >= 0.5 mL, the median TTV was 1.06 (0.51-5.05) mL, with tumour foci of transition zone origin in 16 (84%). The study was limited by its retrospective design and small sample size. CONCLUSIONS Using conservative selection criteria for predicting LV/LG cancer, RP specimens showed organ-confined disease in all cases, upgrading to GS >= 4 + 3 in 6%, and TTV < 0.5 mL in 71% of cases. The transition zone is a common location of under-sampled disease.
引用
收藏
页码:1386 / 1391
页数:6
相关论文
共 16 条
  • [1] 'Insignificant' prostate cancer on prostatectomy and cystoprostatectomy: variation on a theme 'low-volume/low-grade' prostate cancer?
    Trpkov, Kiril
    Yilmaz, Asli
    Bismar, Tarek A.
    Montironi, Rodolfo
    BJU INTERNATIONAL, 2010, 106 (03) : 304 - 315
  • [2] PCA3 SCORE BASED NOMOGRAM TO PREDICT LOW-VOLUME/LOW-GRADE PROSTATE CANCER IN RADICAL PROSTATECTOMY SPECIMENS
    Ward, John F., III
    Graefen, Markus
    Huland, Hartwig
    Koellermann, Jens
    Sauter, Guido
    Wang, Xuemei
    Haese, Alexander
    Troncoso, Patricia
    Babaian, R. Joseph
    Chun, Felix K. H.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 56 - 56
  • [3] NEWLY-DIAGNOSED LOW-VOLUME METASTATIC PROSTATE CANCER; IS THERE A PLACE FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY?
    De Bleser, Elise
    Lumen, Nicolaas
    Buelens, Sarah
    Verla, Wesley
    Claeys, Wietse
    Fonteyne, Valerie
    Verbeke, Sofie
    Villeirs, Geert
    De Man, Kathia
    Rottey, Sylvie
    Van Praet, Charles
    Decaestecker, Karel
    Ost, Piet
    JOURNAL OF UROLOGY, 2021, 206 : E415 - E416
  • [4] Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis
    Bjorklund, Johan
    Cheung, Douglas C. C.
    Martin, Lisa J. J.
    Komisarenko, Maria
    Lajkosz, Katharine
    Hamilton, Robert J. J.
    Zlotta, Alexandre R. R.
    Finelli, Antonio
    SCANDINAVIAN JOURNAL OF UROLOGY, 2023, 57 (1-6) : 29 - 35
  • [5] A nomogram for predicting low-volume/low-grade prostate cancer - A tool in selecting patients for active surveillance
    Nakanishi, Hiroyuki
    Wang, Xuemei
    Ochiai, Atsushi
    Trpkov, Kiril
    Yilmaz, Asli
    Donnelly, J. Bryan
    Davis, John W.
    Troncoso, Patricia
    Babaian, R. Joseph
    CANCER, 2007, 110 (11) : 2441 - 2447
  • [6] A nomogram based on an extended biopsy strategy predicting low-volume/low-grade prostate cancer: A tool in selecting active surveillance patients
    Nakanishi, H.
    Wang, X.
    Ochiai, A.
    Trpkov, K.
    Yilmaz, A.
    Donnelly, J. B.
    Troncoso, P.
    Davis, J.
    Babaian, R. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 202 - 202
  • [7] Cytoreductive radical prostatectomy (CRP) in patients with prostate cancer (PCA) and low-volume osseous metastases.
    Heidenreich, Axel
    Thissen, Andrea K.
    Piper, Charlotte
    Pfister, David J. K. P.
    Porres, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [8] Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?
    Furusato, B.
    Rosner, I. L.
    Osborn, D.
    Ali, A.
    Srivastava, S.
    Davis, C. J.
    Sesterhenn, I. A.
    McLeod, D. G.
    JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (09) : 1038 - 1040
  • [9] THE SIGNIFICANCE OF LOW-GRADE PROSTATE-CANCER ON NEEDLE-BIOPSY - A RADICAL PROSTATECTOMY STUDY OF TUMOR GRADE, VOLUME, AND STAGE OF THE BIOPSIED AND MULTIFOCAL TUMOR
    EPSTEIN, JI
    STEINBERG, GD
    CANCER, 1990, 66 (09) : 1927 - 1932
  • [10] Cytoreductive radical prostatectomy in patients with prostate cancer and low-volume skeletal metastases: Results of a feasibility and case-control study.
    Heidenreich, Axel
    Porres, Daniel
    Kuru, T.
    Pfister, David J. K. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)